1 Product identity
Ingredient risk
1 ingredient to use with caution

Copper 2 mg

BrandBronson LaboratoriesMineral Tablet or Pill 8 ingredients 1 caution DSLD #8593
Net contents: 250 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-06-01
2 Ingredients (8)
IngredientGroupSafety
CalciumCalciumConditionally Safe
CopperCopperConditionally Safe
CelluloseCellulose
Stearic AcidStearic Acid
Magnesium StearateMagnesiumUse with Caution
Sodium CroscarmelloseCroscarmellose Sodium
Hydroxypropyl MethylcelluloseHypromellose
Polyethylene GlycolPolyethylene glycol
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Copper — Conditionally Safe
⚠ Hepatotoxicity at high doses
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID8593
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-06-01
6 More from Bronson Laboratories
View Bronson Laboratories Safety Scorecard → 213 products
5-HTP 100 mgAcetyl L-Carnitine with CoQ-10Adult Bronson Bears Vitamin C 120 mgAdult Natural Soluble FiberAfrican MangoAll Insurance Vitamin Powder
7 Cite this page
Vancouver
Pkhakadze G. Copper 2 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 26]. Available from: https://supplement.ge/products/copper-2-mg-8593/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG